Zosano Announces FDA Submission of New Drug Application for Qtrypta

FREMONT, Calif., Dec. 23, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced the submission of a 505(b)(2) New Drug Application (“NDA”) for...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news